Maintenance therapy with decitabine in younger adults with acute myeloid leukemia in first remission: a phase 2 Cancer and Leukemia Group B Study (CALGB 10503)
William Blum(The Ohio State University), Richard A. Larson(Urbana University), Eva Hoke(Leukemia Research Foundation), Rebecca B. Klisovic(Goethe University Frankfurt), Eunice S. Wang(Roswell Park Comprehensive Cancer Center), Maria R. Baer(University of Maryland, Baltimore), Jessica Kohlschmidt(The Ohio State University), Ben L. Sanford(Duke University), Guido Marcucci(City of Hope), Clara D. Bloomfield(North Shore University Hospital), Jonathan E. Kolitz(Memorial Sloan Kettering Cancer Center), Richard M. Stone(Dana-Farber Cancer Institute), Krzysztof Mrózek(The Ohio State University), Daniel J. DeAngelo(Dana-Farber Cancer Institute), Geoffrey L. Uy(Memorial Sloan Kettering Cancer Center), Bayard L. Powell(Atrium Health Wake Forest Baptist), Susan Geyer(University of South Florida), Wendy Stock(University of Chicago)
Cited by 83
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
|Blood|2009|4.4k